Establishment and Comprehensive Characterization of a Novel Preclinical Platform of Metastatic Retinoblastoma for Therapeutic Developments.

Zugbi S, Aschero R, Ganiewich D, Cancela MB, Winter U, Ottaviani D, Sampor C, Dinardi M, Torbidoni AV, Mena M, Balaguer-Lluna L, Lamas G, Sgroi M, Lagomarsino E, Lubieniecki F, Fandiño A, Radvanyi F, Abramson DH, Podhajcer O, Llera AS, Cafferata EG, Chantada G, Carcaboso AM, Schaiquevich P

Open source

DOI: 10.1167/iovs.64.15.27
Published: 2023 Dec 1
Container: Investigative ophthalmology & visual science
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1167/iovs.64.15.27,
  title = {Establishment and Comprehensive Characterization of a Novel Preclinical Platform of Metastatic Retinoblastoma for Therapeutic Developments.},
  author = {Zugbi S and Aschero R and Ganiewich D and Cancela MB and Winter U and Ottaviani D and Sampor C and Dinardi M and Torbidoni AV and Mena M and Balaguer-Lluna L and Lamas G and Sgroi M and Lagomarsino E and Lubieniecki F and Fandiño A and Radvanyi F and Abramson DH and Podhajcer O and Llera AS and Cafferata EG and Chantada G and Carcaboso AM and Schaiquevich P},
  year = {2023},
  journal = {Investigative ophthalmology \& visual science},
  doi = {10.1167/iovs.64.15.27},
  url = {https://doi.org/10.1167/iovs.64.15.27}
}

RIS

TY  - JOUR
TI  - Establishment and Comprehensive Characterization of a Novel Preclinical Platform of Metastatic Retinoblastoma for Therapeutic Developments.
AU  - Zugbi S
AU  - Aschero R
AU  - Ganiewich D
AU  - Cancela MB
AU  - Winter U
AU  - Ottaviani D
AU  - Sampor C
AU  - Dinardi M
AU  - Torbidoni AV
AU  - Mena M
AU  - Balaguer-Lluna L
AU  - Lamas G
AU  - Sgroi M
AU  - Lagomarsino E
AU  - Lubieniecki F
AU  - Fandiño A
AU  - Radvanyi F
AU  - Abramson DH
AU  - Podhajcer O
AU  - Llera AS
AU  - Cafferata EG
AU  - Chantada G
AU  - Carcaboso AM
AU  - Schaiquevich P
PY  - 2023
JO  - Investigative ophthalmology & visual science
DO  - 10.1167/iovs.64.15.27
UR  - https://doi.org/10.1167/iovs.64.15.27
ER  -

APA

S, Z., R, A., D, G., MB, C., U, W., D, O., C, S., M, D., AV, T., M, M., L, B., G, L., M, S., E, L., F, L., A, F., F, R., DH, A., O, P., AS, L., EG, C., G, C., AM, C., & P, S. (2023). Establishment and Comprehensive Characterization of a Novel Preclinical Platform of Metastatic Retinoblastoma for Therapeutic Developments.. Investigative ophthalmology & visual science. https://doi.org/10.1167/iovs.64.15.27

Source records

pubmed · retrieved 2026-09-26T07:09:10.797Z